QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: Posterior Reversible Encephalopathy Syndrome Associated With Medicinal Products

Test your understanding of the concepts covered by Posterior Reversible Encephalopathy Syndrome (PRES) Associated With Medicinal Products.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Which finding most strongly supports a diagnosis of PRES in an appropriate clinical setting?

MRI areas of predominantly vasogenic oedema with increased T2/FLAIR signal, often involving parieto-occipital regions A normal MRI with isolated fever and neck stiffness A focal arterial occlusion with a territorial infarction as the only abnormality A chronic pattern of cerebral atrophy without acute symptoms

Question 2 of 10 Why can antiangiogenic medicines plausibly contribute to PRES?

They invariably cause direct destruction of cerebral neurons They can affect endothelial biology and increase blood pressure, potentially impairing cerebral vascular regulation They prevent vasogenic oedema by stabilising all blood vessels Their association is based only on the fact that they are used in oncology

Question 3 of 10 Which exposure-history element is most important when evaluating several potentially contributory medicines?

The medicine with the highest retail cost The medicine listed first in the source report Initiation, discontinuation, dose changes and re-exposure for each relevant product, aligned with symptom and precipitant timing Only the medicine administered immediately before hospital admission

Question 4 of 10 Which statement about seriousness and expectedness is correct?

Because PRES can be severe, every case has the same seriousness outcome and is automatically unexpected Seriousness is assessed according to the facts of the individual case, while expectedness requires comparison with applicable reference safety information Expectedness is determined solely by whether the patient required hospitalisation A serious case automatically establishes a causal relationship

Question 5 of 10 What does temporal compatibility contribute to individual case causality assessment?

It is a necessary condition for causality but does not by itself establish that the medicine caused PRES It proves causality whenever symptoms follow treatment initiation It is unnecessary if the product has a known association It is relevant only when the patient has no alternative risk factors

Question 6 of 10 A patient has seizures, visual disturbance and MRI abnormalities involving the frontal lobes and brainstem, without parieto-occipital involvement. What is the most appropriate interpretation?

PRES is excluded because posterior involvement is mandatory The findings are compatible with an atypical distribution of PRES and require clinical correlation The findings establish a medicinal-product-induced event The imaging must represent intracranial haemorrhage

Question 7 of 10 Which statement best distinguishes diagnostic assessment from causality assessment in a suspected PRES case?

A confirmed PRES diagnosis proves that the most recently used medicine caused the event If causality is uncertain, the diagnosis of PRES cannot be assessed The reviewer must separately assess whether the clinical and imaging findings support PRES and whether the medicine plausibly contributed Causality assessment should precede review of the clinical phenotype

Question 8 of 10 Which interpretation of therapeutic drug concentrations is most appropriate in a suspected calcineurin-inhibitor-associated PRES case?

A therapeutic concentration excludes a relationship with PRES A therapeutic concentration may still be compatible with PRES because susceptibility and endothelial or vascular mechanisms may not depend on overdose Only a supratherapeutic concentration can be considered relevant Concentration data are always more informative than clinical chronology and competing causes

Question 9 of 10 Which conclusion is most appropriate when a signal consists of many poorly documented cases but lacks consistent imaging, latency or alternative-cause information?

The high case count proves a strong causal association The signal should be ignored because case reports are never useful The apparent signal requires careful validation, because quantity without case coherence may provide limited causal information The product should automatically be contraindicated

Question 10 of 10 A spontaneous report is coded as PRES but contains no MRI details and describes seizures during sepsis and acute renal failure. What is the most appropriate initial pharmacovigilance approach?

Treat the coded term as a confirmed diagnosis and assign causality to the suspected medicine Discard the report because PRES cannot occur during sepsis Seek targeted follow-up where feasible and record the diagnostic and causal uncertainty while assessing the substantial competing explanations Assign causality to the medicine that was administered most recently

QPPV.com

Knowledge Assessment: Posterior Reversible Encephalopathy Syndrome Associated With Medicinal Products

Cookie Settings